STOCK TITAN

BioCryst to Report Second Quarter 2025 Financial Results on August 4

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

BioCryst Pharmaceuticals (Nasdaq: BCRX) has scheduled its second quarter 2025 financial results announcement for Monday, August 4, 2025. The company will host a conference call and webcast at 8:30 a.m. ET to discuss the financial results and provide a corporate update.

Investors can access the live call by dialing 1-844-481-2942 (domestic) or 1-412-317-1866 (international). A live webcast and replay will be available in the investors section at www.biocryst.com.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-1.05% News Effect

On the day this news was published, BCRX declined 1.05%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

RESEARCH TRIANGLE PARK, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2025 financial results on Monday, August 4, 2025.

BioCryst management will host a conference call and webcast at 8:30 a.m. ET that day to discuss the financial results and provide a corporate update.

The live call may be accessed by dialing 1-844-481-2942 for domestic callers and 1-412-317-1866 for international callers. A live webcast and replay of the call will be available online in the investors section of the company website at www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com


FAQ

When will BioCryst (BCRX) report Q2 2025 earnings?

BioCryst will report its Q2 2025 financial results on Monday, August 4, 2025 at 8:30 a.m. ET.

How can I access BioCryst's Q2 2025 earnings call?

Investors can access the live call by dialing 1-844-481-2942 (domestic) or 1-412-317-1866 (international), or via webcast on BioCryst's website at www.biocryst.com.

Where can I find the replay of BioCryst's Q2 2025 earnings webcast?

The webcast replay will be available in the investors section of BioCryst's website at www.biocryst.com.

What time is BioCryst's Q2 2025 earnings call?

BioCryst's Q2 2025 earnings call is scheduled for 8:30 a.m. ET on Monday, August 4, 2025.
Biocryst Pharmaceuticals Inc

NASDAQ:BCRX

BCRX Rankings

BCRX Latest News

BCRX Latest SEC Filings

BCRX Stock Data

1.64B
206.83M
1.26%
95.59%
13.09%
Drug Manufacturers - Specialty & Generic
Biological Products, (no Disgnostic Substances)
Link
United States
DURHAM